The future of the GLP-1 drug market is driven by key trends, including patent expirations, manufacturing challenges, and advancements in drug delivery
Theres a black market production, primarily in China, that sends large amounts of these peptides to the United States with the label For research only, says Pinchas Cohen, MD, dean and distinguished professor of gerontology, medicine, and biological sciences at the USC Leonard Davis School of Gerontology, who has discovered several investigational peptides
The weight and metabolic effects of GLP-1s seem to wane after people stop the medication, but doctors dont yet have much long-term data on these effects
And flavonoids are plant compounds that have antioxidant and anti-inflammatory properties, but they also increase and enhance GLP one